Partnered Podcast

In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu CULIE, Head of MAB, Pierre Fabre, to discuss the challenges in the development and manufacturing of ADCs.

In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials.

In this podcast, Janelle Hart, Managing Editor, Citeline, joins together with industry experts, Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.

In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment.

The US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.    Learn how molecular technology is enhancing patient safety for CAR-T clinical trials.  

Listen in as Citeline sits down with a regulatory and compliance expert from Advanced Clinical. Capture new insights into the present state of regulatory as advancements in technology, a shift to patient-centricity, and the globalization of clinical trials combine to change workflows and trial design. Plan your strategy now and develop new ways to master these complexities, with information from this free podcast.

Generics Bulletin sat down with executives from Centrient Pharmaceuticals, a global leader in sustainable, enzymatic antibiotics, next-generation statins, and anti-fungals, to discuss innovations and strategic development capabilities in biotechnology.

Listen in as experts Cheryle Evans, SVP, Global Clinical & Biometric Operations and Caroline Redeker, Senior Vice President, Corporate Development at Advanced Clinical discuss the evolution of the decentralized clinical trial model and what it means in a post-COVID landscape.